AR and neoplasm: Research indicates that progression is closely associated with androgen receptor (AR) signaling, loss of tumor suppressor genes, growth factor signaling, metabolic changes, the immune system, and the tumor microenvironment (TME) [13,14,20,21,22,23,24].